Appeal No. 2003-1106 Application No. 09/825,896 view of their identicalness. As the examiner correctly points out on page 4 of the Answer, appellant’s specification (page 4 at lines 20-22) discloses that the instant compound has an affinity for FKBP-type immunophillins and that it does not exert any significant immunosuppressive activity. Hence, we agree with the examiner that the functional aspects of the claims of Steiner are met by the subject matter of the instant claims. Appellants’ arguments do not show how the functional aspects would not be met. Appellants also do not provide convincing arguments showing how one set of claims would be literally infringed, while the other set of claims would not be literally infringed. III. Conclusion In view of the above, we therefore affirm the rejection. 8Page: Previous 1 2 3 4 5 6 7 8 9 10 NextLast modified: November 3, 2007